Erin Moore
InvestorExecutive Assistant at Third Rock Ventures Β· Board director at Strand Therapeutics
East Coast
Find your path to Erin
764 people in our graph share verified history with Erin β schools, employers, funds. One of them is your warm intro.
Wesley ChanunlockedErin: together at Massachusetts Institute of Technology (1996β2000)
Γ5Erin: together at Massachusetts Institute of Technology
Γ2Erin: together at GlaxoSmithKline
Erin: together at ROME Therapeutics
About
Erin Moore provides administrative support to venture partners at Third Rock and collaborates with the firm's Discovery project teams. She is motivated by the impact of life sciences work on patients.
ContactΒ· self-published, not guessed
Invests in
BiotechDigital HealthHealthtech
Board director at Strand Therapeutics
Intro paths
β
In turn, Erin can intro founders to Strand Therapeutics's investors below.
Strand Therapeutics's investors Β· 9
Amgen VenturesThousand Oaks Β· $1M β $3M checksANRITokyo Β· $497K β $78M checksFPVJackson Β· $100K β $5M checks Β· since 2026ICONIQSan Francisco Β· since 2025JIC Venture Growth InvestmentsTokyoKinnevikStockholm Β· since 2025LG Technology VenturesSanta Clara Β· since 2025Playground GlobalPalo Alto Β· $1M β $20M checks Β· since 2025Third Rock VenturesBoston Β· $100K β $5M checks Β· since 2025
Co-founders at Strand Therapeutics
TK

Tasuku KitadaExecutive Officer, Director, Promoter
JB

Jacob BecraftExecutive Officer, Director, Promoter
Experience
- Third Rock VenturesVenture Partnercurrent2026 β presentBoston, Massachusetts, United States
- Strand TherapeuticsDirector Board of Directorscurrent2025 β presentBoston, Massachusetts, United States
- Cardurion PharmaceuticalsMember of the Boardcurrent2018 β presentCambridge, MA
- Nimbus TherapeuticsFormer Chief Executive Officer2025 β 2026
- Nimbus TherapeuticsCEO2018 β 2025Cambridge, MA
- Nimbus TherapeuticsChief Financial Officer2017 β 2018Cambridge, MA
- Nimbus TherapeuticsChief Business Officer2014 β 2018Cambridge, MA
- ROME TherapeuticsBoard Member2019 β 2026Cambridge, Massachusetts, United States
- GlaxoSmithKlineVP, Business Development, GSK Oncology2011 β 2014
- GlaxoSmithKlineHead, Acquisitions and Divestitures2009 β 2011
- GlaxoSmithKlineDirector, WW Business Development2008
- GlaxoSmithKlineDirector, R&D Executive Operations2005 β 2008
- McKinsey & Co.Engagement Manager2004 β 2005
- TransForm PharmaceuticalsBusiness Development Manager2003 β 2004
- Massachusetts General HospitalPharmacy Pharmacoeconomic Analyst2002 β 2003
- McKinsey & Co.Business Analyst2000 β 2002
- Mitsubishi Chemical CompanyEngineering Consultant2000
- PfizerScientist I, Pharmaceutical Sciences1998 β 1999
Skills & more
Global Business Development3M&A experience2
Languages German, broken
From Erin's professional profile.
Colleagues at Third Rock Ventures
Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alexis Borisy
General Partner at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures
Frequently asked questions
- Who is Erin Moore?
- Erin Moore provides administrative support to venture partners at Third Rock and collaborates with the firm's Discovery project teams. She is motivated by the impact of life sciences work on patients.
- Where does Erin Moore work?
- Erin Moore is Executive Assistant at Third Rock Ventures and Board director at Strand Therapeutics.
- What does Erin Moore invest in?
- Erin Moore invests in Biotech, Digital Health, Healthtech.
- Where did Erin Moore go to school?
- Erin Moore studied at MIT Sloan School of Management (MBA, Finance, Marketing, Entrepreneurship); Massachusetts Institute of Technology (MS, Chemical Engineering); Massachusetts Institute of Technology (BS, Chemistry).
Same school
Also attended MIT Sloan School of Management935
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor
+ 929 more
Also attended Massachusetts Institute of Technology2,000
Fred WilsonCo-founder & Partner at Union Square VenturesElad GilSolo general partner investing through Gil CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystPhilippe LaffontFounder & CIO of Coatue ManagementNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDG
+ 1,994 more
Shared employers
Also worked at Cardurion Pharmaceuticals2
Also worked at Nimbus Therapeutics10
Jeb KeiperInvestor at Third Rock VenturesVikas GoyalPartner at Longwood FundNikolaInvestment Committee Member at ACF InvestorsNikola TrbovicManaging Partner at SV Health InvestorsAlex Badamchi-ZadehVice President at SV Health InvestorsRosana KapellerInvestor at GV (Google Ventures)
+ 4 more
Also worked at GlaxoSmithKline279
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at MedicxiJeb KeiperInvestor at Third Rock VenturesJane SuhPrincipal on the AlleyCorp Healthcare teamCarol SuhPartner at ARCH Venture PartnersRudina SeseriFounder and Managing Partner at Glasswing Ventures
+ 273 more
Also worked at McKinsey & Co.2,000
Elad GilSolo general partner investing through Gil CapitalJim BreyerFounder & CEO of Breyer CapitalAnn Miura-KoCo-founding Partner at FloodgateJeremy LiewPartner at Lightspeed Venture PartnersMike SpeiserManaging Director at Sutter Hill VenturesJeremy LevinePartner at Bessemer Venture Partners
+ 1,994 more









































